Analysis in a group dosing study [Bioanalytics]

posted by jag009  – NJ, 2015-07-22 18:23 (3492 d 12:35 ago) – Posting: # 15127
Views: 3,640

Hi,

❝ We are planning to conduct a FDA submission study in 3 groups (due to logistic limitations).


Is this a parallel study or a crossover study with groups?

You have a timeline issue? If not, I would prefer to finish all dosing and PK samplings before starting bioanalytical.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
33 visitors (0 registered, 33 guests [including 7 identified bots]).
Forum time: 05:59 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5